Writers, Readers, and Erasers of Epigenetic Marks

Thomas B. Nicholson, Nicolas Veland, Taiping Chen

Research output: Chapter in Book/Report/Conference proceedingChapter

27 Scopus citations

Abstract

Changes in gene expression and activity underlie the formation of cancerous tumors. Historically, alterations (deletions, point mutations, translocations, etc.) in the DNA genome of the cell were believed to be the basis for tumor formation, but recent studies have demonstrated that epigenetic modifications, which involve the regulated addition of chemical groups to DNA and histones, also profoundly affect gene expression and, thus, cancer. Both genomic region compaction and gene expression are modulated by epigenetic modifications, which are deposited by specific enzymes (known as "writers"), and subsequently recognized by effector proteins ("readers"). Most, if not all, epigenetic marks are reversible, and various enzymes ("erasers") remove these marks. The complex interplay of these three classes of proteins controls gene transcription, and defects in this system contribute to cancer initiation and progression. This chapter will introduce the key concepts surrounding these three types of proteins, with a particular focus on methyl and acetyl marks.

Original languageEnglish (US)
Title of host publicationEpigenetic Cancer Therapy
PublisherElsevier Inc.
Pages31-66
Number of pages36
ISBN (Electronic)9780128002247
ISBN (Print)9780128002063
DOIs
StatePublished - Jul 22 2015

Keywords

  • Acetylation
  • Cancer
  • Demethylation
  • Epigenetics
  • Methylation
  • Therapeutics

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Writers, Readers, and Erasers of Epigenetic Marks'. Together they form a unique fingerprint.

Cite this